NO20025220L - Ny fremgangsmåte - Google Patents
Ny fremgangsmåteInfo
- Publication number
- NO20025220L NO20025220L NO20025220A NO20025220A NO20025220L NO 20025220 L NO20025220 L NO 20025220L NO 20025220 A NO20025220 A NO 20025220A NO 20025220 A NO20025220 A NO 20025220A NO 20025220 L NO20025220 L NO 20025220L
- Authority
- NO
- Norway
- Prior art keywords
- new procedure
- stable
- formoterol
- copd
- rhinitis
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 abstract 1
- 229960002848 formoterol Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Catalysts (AREA)
- Saccharide Compounds (AREA)
- Separation By Low-Temperature Treatments (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0012261.4A GB0012261D0 (en) | 2000-05-19 | 2000-05-19 | Novel process |
| PCT/SE2001/001117 WO2001089491A1 (en) | 2000-05-19 | 2001-05-17 | Novel process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20025220L true NO20025220L (no) | 2002-10-31 |
| NO20025220D0 NO20025220D0 (no) | 2002-10-31 |
Family
ID=9892016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20025220A NO20025220D0 (no) | 2000-05-19 | 2002-10-31 | Ny fremgangsmÕte |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US7179489B2 (no) |
| EP (1) | EP1289505B1 (no) |
| JP (3) | JP5739597B2 (no) |
| KR (1) | KR100799452B1 (no) |
| CN (1) | CN1245962C (no) |
| AT (1) | ATE276748T1 (no) |
| AU (2) | AU5900601A (no) |
| BR (1) | BRPI0110947B8 (no) |
| CA (1) | CA2409660C (no) |
| DE (1) | DE60105807T2 (no) |
| ES (1) | ES2227190T3 (no) |
| GB (1) | GB0012261D0 (no) |
| IL (2) | IL152532A0 (no) |
| MX (1) | MXPA02011310A (no) |
| NO (1) | NO20025220D0 (no) |
| NZ (1) | NZ522419A (no) |
| PT (1) | PT1289505E (no) |
| WO (1) | WO2001089491A1 (no) |
| ZA (1) | ZA200208710B (no) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| AU2003269989B8 (en) | 2002-08-21 | 2009-11-12 | Norton Healthcare Ltd. | Inhalation composition |
| GB0219511D0 (en) | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
| CA2500065A1 (en) * | 2002-09-30 | 2004-04-15 | Acusphere, Inc. | Sustained release porous microparticles for inhalation |
| AU2003293833B2 (en) | 2002-12-12 | 2009-10-01 | Covis Pharma B.V. | Combination medicament |
| US6962006B2 (en) * | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
| US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
| GB0312148D0 (en) | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
| GB0315889D0 (en) | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| BRPI0413129A (pt) * | 2003-07-29 | 2006-10-03 | Boehringer Ingelheim Int | medicamentos para inalação compreendendo betamiméticos e anticolinérgico |
| PL1670482T5 (pl) | 2003-09-16 | 2022-10-03 | Covis Pharma Gmbh | Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego |
| GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| JP2008502699A (ja) * | 2004-06-14 | 2008-01-31 | セプラコール・インコーポレイテッド | 肺疾患治療方法、及びそのための組成物 |
| JP5156397B2 (ja) | 2005-02-10 | 2013-03-06 | グラクソ グループ リミテッド | 予備分級技術を用いて乳糖を製造する方法及びその乳糖から形成させた医薬製剤 |
| CA2631492A1 (en) * | 2005-12-15 | 2007-06-21 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for oral administration |
| US7913223B2 (en) * | 2005-12-16 | 2011-03-22 | Dialogic Corporation | Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system |
| CN101342155B (zh) * | 2007-07-11 | 2012-01-04 | 天津帝士力投资控股集团有限公司 | 一种(r,r)-福莫特罗吸入粉雾剂及其制备方法 |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| WO2010144043A1 (en) * | 2009-06-12 | 2010-12-16 | Astrazeneca Ab | A novel 4-methylbenzenesulphonate salt and a process for preparing a pharmaceutical composition comprising the salt |
| GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| PL2538922T3 (pl) * | 2010-02-25 | 2016-11-30 | Formułowanie kompozycji do leczenia stanów zapalnych | |
| TR201007250A2 (tr) * | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Selobioz içeren formülasyon. |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| EP2804583A1 (en) * | 2012-01-16 | 2014-11-26 | Mahmut Bilgic | Dry powder formulations comprising r-formoterol as active agent |
| WO2013109208A1 (en) * | 2012-01-16 | 2013-07-25 | Mahmut Bilgic | Formulations comprising formoterol as active agent |
| KR20200015828A (ko) * | 2012-02-28 | 2020-02-12 | 아이슈티카 홀딩스 인코포레이티드. | 흡입용 약제학적 조성물 |
| KR102898819B1 (ko) | 2019-09-24 | 2025-12-12 | 키에시 파르마슈티시 엣스. 피. 에이. | 흡입용 건조 분말 제제를 위한 신규 담체 입자 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2514078B2 (ja) * | 1988-08-22 | 1996-07-10 | エスエス製薬株式会社 | 圧縮成型製剤 |
| US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
| SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| ES2079743T3 (es) * | 1991-07-01 | 1996-01-16 | Gergely Gerhard | Tableta para chupar o masticar. |
| JPH0558911A (ja) * | 1991-08-27 | 1993-03-09 | N D Shinyaku Kaihatsu Kenkyusho:Kk | 鎮咳去痰剤 |
| SK282826B6 (sk) | 1991-12-18 | 2002-12-03 | Aktiebolaget Astra | Farmaceutická kompozícia na podávanie inhaláciou s obsahom formoterolu a budesonidu a jej použitie |
| SE9404080L (sv) | 1993-12-28 | 1995-06-29 | Ciba Geigy Ag | Förfarande för framställning av en optiskt ren enantiomer av formoterol |
| SE9700134D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| SE9700136D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| SE9700133D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
| SE9802073D0 (sv) * | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
| CA2347856C (en) | 1998-11-13 | 2009-02-17 | Jagotec Ag | Dry powder for inhalation |
| US6034604A (en) * | 1999-01-14 | 2000-03-07 | Kaltner; George | Deactivation prevention for electronic article surveillance systems |
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
-
2000
- 2000-05-19 GB GBGB0012261.4A patent/GB0012261D0/en not_active Ceased
-
2001
- 2001-05-17 NZ NZ522419A patent/NZ522419A/en not_active IP Right Cessation
- 2001-05-17 JP JP2001585736A patent/JP5739597B2/ja not_active Expired - Lifetime
- 2001-05-17 ES ES01932484T patent/ES2227190T3/es not_active Expired - Lifetime
- 2001-05-17 US US10/276,458 patent/US7179489B2/en not_active Expired - Lifetime
- 2001-05-17 MX MXPA02011310A patent/MXPA02011310A/es active IP Right Grant
- 2001-05-17 KR KR1020027015533A patent/KR100799452B1/ko not_active Expired - Lifetime
- 2001-05-17 AU AU5900601A patent/AU5900601A/xx active Pending
- 2001-05-17 BR BRPI0110947A patent/BRPI0110947B8/pt not_active IP Right Cessation
- 2001-05-17 DE DE60105807T patent/DE60105807T2/de not_active Expired - Lifetime
- 2001-05-17 CN CNB018097227A patent/CN1245962C/zh not_active Expired - Lifetime
- 2001-05-17 WO PCT/SE2001/001117 patent/WO2001089491A1/en not_active Ceased
- 2001-05-17 AU AU2001259006A patent/AU2001259006B2/en not_active Expired
- 2001-05-17 IL IL15253201A patent/IL152532A0/xx active IP Right Grant
- 2001-05-17 CA CA2409660A patent/CA2409660C/en not_active Expired - Lifetime
- 2001-05-17 PT PT01932484T patent/PT1289505E/pt unknown
- 2001-05-17 AT AT01932484T patent/ATE276748T1/de active
- 2001-05-17 EP EP01932484A patent/EP1289505B1/en not_active Revoked
-
2002
- 2002-10-28 ZA ZA200208710A patent/ZA200208710B/xx unknown
- 2002-10-31 NO NO20025220A patent/NO20025220D0/no not_active Application Discontinuation
-
2007
- 2007-01-25 US US11/627,051 patent/US7670625B2/en not_active Expired - Fee Related
-
2010
- 2010-01-14 US US12/687,691 patent/US20100183729A1/en not_active Abandoned
-
2012
- 2012-05-14 IL IL219785A patent/IL219785A/en active IP Right Grant
- 2012-11-27 JP JP2012258478A patent/JP2013040214A/ja active Pending
-
2014
- 2014-12-04 JP JP2014246231A patent/JP2015042693A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20025220D0 (no) | Ny fremgangsmÕte | |
| IL152470A0 (en) | Pharmaceutical composition comprising micronised formoterol and micronised glucocorticosteroid | |
| IS6444A (is) | Pýrimidín karboxamíð nytsamleg sem latar á PDE4 samsætuensím | |
| AU2001295760A1 (en) | Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders | |
| DE60120936D1 (de) | Behandlung von atemerkrankungen | |
| SE0200356D0 (sv) | Novel use | |
| SE9900833D0 (sv) | Novel combination | |
| EA200500328A1 (ru) | Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства | |
| MY145166A (en) | Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof | |
| SE9900834D0 (sv) | Novel combination | |
| MXPA04007294A (es) | Composicion para inhalacion. | |
| WO2002095008A3 (en) | Methods of modulating surfactant phospholipid production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |